• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-内酰胺酶抑制剂的演变

Evolution of beta-lactamase inhibitors.

作者信息

Rolinson G N

机构信息

Research Division, Beecham Pharmaceuticals, Betchworth, Surrey, England.

出版信息

J Reprod Med. 1988 Jun;33(6 Suppl):571-3.

PMID:3294401
Abstract

Beta-lactamase, the bacterial enzyme that can inactivate penicillins, cephalosporins and related antibiotics, can function outside the cell or in the periplasmic space. This resistance can be transferred between bacteria of the same or different species. Most strains of Staphylococcus aureus, Staphylococcus epidermidis, Klebsiella, Enterobacter, Pseudomonas aeruginosa and Bacteroides species are beta-lactamase producers. Clavulanic acid is a beta-lactamase inhibitor that works by blocking the enzyme center. When it is combined with amoxicillin and ticarcillin, it expands those drugs' spectrum of activity to bacteria that are resistant to the single antibiotics as well as to anaerobic bacteria.

摘要

β-内酰胺酶是一种可使青霉素、头孢菌素及相关抗生素失活的细菌酶,它可在细胞外或周质空间发挥作用。这种耐药性可在同种或不同种细菌之间转移。金黄色葡萄球菌、表皮葡萄球菌、克雷伯菌属、肠杆菌属、铜绿假单胞菌和拟杆菌属的大多数菌株都是β-内酰胺酶产生菌。克拉维酸是一种β-内酰胺酶抑制剂,其作用机制是阻断酶的活性中心。当它与阿莫西林和替卡西林联合使用时,可将这些药物的活性谱扩展至对单一抗生素耐药的细菌以及厌氧菌。

相似文献

1
Evolution of beta-lactamase inhibitors.β-内酰胺酶抑制剂的演变
J Reprod Med. 1988 Jun;33(6 Suppl):571-3.
2
Development of beta-lactamase inhibitors.β-内酰胺酶抑制剂的研发。
J Reprod Med. 1990 Mar;35(3 Suppl):307-12.
3
Evolution of beta-lactamase inhibitors.β-内酰胺酶抑制剂的演变
Surg Gynecol Obstet. 1991;172 Suppl:11-6.
4
Parenteral beta-lactamase inhibitor combinations for clinical use.
Am Fam Physician. 1995 May 15;51(7):1695-8.
5
Evolution of beta-lactamase inhibitors.
Pharmacotherapy. 1991;11(2 ( Pt 2)):37S-39S.
6
Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
Drugs Exp Clin Res. 1996;22(1):9-15.
7
Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.β-内酰胺酶抑制剂对金黄色葡萄球菌菌株中氨苄西林和阿莫西林最低抑菌浓度的影响。
Rev Latinoam Microbiol. 1998 Jul-Dec;40(3-4):128-34.
8
Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
Int J Tissue React. 1995;17(5-6):199-203.
9
Bacteriological investigations with beta-lactamase inhibitors.β-内酰胺酶抑制剂的细菌学研究。
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol. 1982 Jun;252(2):222-9.
10
[Beta-lactamase inhibitors].[β-内酰胺酶抑制剂]
G Ital Chemioter. 1982 Jan-Jun;29(1):1-10.